Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistance and resilience to Alzheimer’s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort
Caitlin S. Latimer, Bridget Teevan Burke, Nicole F. Liachko, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
Joana B. Pereira, Shorena Janelidze, Rik Ossenkoppele, et al.
Brain (2020) Vol. 144, Iss. 1, pp. 310-324
Open Access | Times Cited: 164
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
Peter T. Nelson, Carol Brayne, Margaret E. Flanagan, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 1, pp. 27-44
Open Access | Times Cited: 110
LATE-NC staging in routine neuropathologic diagnosis: an update
Peter T. Nelson, Edward B. Lee, Matthew D. Cykowski, et al.
Acta Neuropathologica (2022) Vol. 145, Iss. 2, pp. 159-173
Open Access | Times Cited: 89
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Geetika Nehra, Bjoern Bauer, Anika M. S. Hartz
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108119-108119
Open Access | Times Cited: 69
Sex and gender differences in cognitive resilience to aging and Alzheimer's disease
Eider M. Arenaza‐Urquijo, Rory Boyle, Kaitlin B. Casaletto, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5695-5719
Open Access | Times Cited: 35
The concept of resilience to Alzheimer’s Disease: current definitions and cellular and molecular mechanisms
Luuk E. de Vries, Inge Huitinga, Helmut W. Kessels, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
Sandra O. Tomé, Rik Vandenberghe, Simona Ospitalieri, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 83
Translational approaches to understanding resilience to Alzheimer’s disease
Sarah M. Neuner, Maria A. Telpoukhovskaia, Vilas Menon, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 369-383
Open Access | Times Cited: 46
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Dietmar Rudolf Thal, Sandra O. Tomé
Brain Research Bulletin (2022) Vol. 190, pp. 204-217
Open Access | Times Cited: 46
Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling
Jamie M. Walker, Shiva Kazempour Dehkordi, Anna Fracassi, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 38
Integrated multimodal cell atlas of Alzheimer’s disease
Mariano I. Gabitto, Kyle J. Travaglini, Jeannelle Ariza, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 32
TDP-43 pathology is associated with increased tau burdens and seeding
Sandra O. Tomé, Grigoria Tsaka, Alicja Ronisz, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 28
Integrated multimodal cell atlas of Alzheimer’s disease
Mariano I. Gabitto, Kyle J. Travaglini, Victoria M. Rachleff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 24
Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1
Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
Gavrilova Si, Antón Álvarez
Medicinal Research Reviews (2020) Vol. 41, Iss. 5, pp. 2775-2803
Closed Access | Times Cited: 51
Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old
Thomas J. Montine, María M. Corrada, Claudia H. Kawas, et al.
Neurology (2022) Vol. 99, Iss. 10
Open Access | Times Cited: 31
Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer’s disease neuropathologic change
Pietro Scaduto, Julie C. Lauterborn, Conor D. Cox, et al.
Acta Neuropathologica (2022) Vol. 145, Iss. 3, pp. 303-324
Open Access | Times Cited: 29
TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
Caitlin S. Latimer, Jade G. Stair, Joshua C. Hincks, et al.
Disease Models & Mechanisms (2022) Vol. 15, Iss. 4
Open Access | Times Cited: 28
Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change
Pamela J. McMillan, Sarah J. Benbow, Rikki L. Uhrich, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3206-3220
Open Access | Times Cited: 17
Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response
Luuk E. de Vries, Aldo Jongejan, Jennifer Monteiro Fortes, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
Wendi Huang, Yongjian Zhou, Lin Tu, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 41
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
Michael Tran Duong, Sandhitsu R. Das, Xueying Lyu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease
Laura E.M. Wisse, Anika Wuestefeld, Melissa Murray, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease
Marta J. Koper, Sandra O. Tomé, Klara Gawor, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top